Evidence map›Paper›PMID 25591541›Full record

ArticleVirology journal2015

Identification of human papillomaviruses from formalin-fixed, paraffin-embedded pre-cancer and invasive cervical cancer specimens in Zambia: a cross-sectional study.

Allen C Bateman, Katundu Katundu, Pascal Polepole, Aaron Shibemba, Mulindi Mwanahamuntu, Dirk P Dittmer, Groesbeck P Parham, Carla J Chibwesha

Open access · goldAbstract read
In one paragraph

Article in Virology journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. HPVAnalytical cellular pathology (Amsterdam) · 2019
    Article
  6. A high prevalence of human papillomavirus 16 and 18 co-infections in cervical biopsies from southern Brazil.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2018
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Allen C BatemanCentre for Infectious Disease Research in Zambia, Plot 5032 Great North Road, Lusaka, Zambia. bateman.allen@gmail.com.
Katundu KatunduCentre for Infectious Disease Research in Zambia, Plot 5032 Great North Road, Lusaka, Zambia. Katundu.Katundu@cidrz.org.
Pascal PolepoleUniversity of Zambia Teaching Hospital, Lusaka, Zambia. poleman1981@gmail.com.
Aaron ShibembaUniversity of Zambia Teaching Hospital, Lusaka, Zambia. shibemba@yahoo.com.
Mulindi MwanahamuntuCentre for Infectious Disease Research in Zambia, Plot 5032 Great North Road, Lusaka, Zambia. mulindim@gmail.com.
Dirk P DittmerProgram in Global Oncology, UNC Lineberger Comprehensive Cancer Center and School of Medicine, UNC, Chapel Hill, North Carolina, USA. dirk_dittmer@med.unc.edu.
Groesbeck P ParhamCentre for Infectious Disease Research in Zambia, Plot 5032 Great North Road, Lusaka, Zambia. professorparham@gmail.com.
Carla J ChibweshaCentre for Infectious Disease Research in Zambia, Plot 5032 Great North Road, Lusaka, Zambia. Carla.Chibwesha@cidrz.org.
Centre for Infectious Disease Research in Zambia · ZMUniversity of Zambia · ZMUNC Lineberger Comprehensive Cancer CenterUniversity of North Carolina at Chapel Hill · US

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
Vironomics and Biostatistics CoreP01CA019014 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JACK D GRIFFITH · 1985 to 2026
$43.8M
ART Modulation of Viral Pathogenesis in Oral EpitheliaR01DE018304 · NIDCR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DITTMER, DIRK P · 2007 to 2025
$6.9M
Fogarty Global Health Fellows Coordinating CenterR25TW009340 · FIC · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CHI, BENJAMIN H. · 2012 to 2016
$6.9M
Zambian Cervical Cancer Research Capacity InitiativeD43CA153784 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI PARHAM, GROESBECK PREER · 2010 to 2013
$1.8M
FIC NIH HHS R25 TW009340FIC NIH HHS R25TW009340NCI NIH HHS 1D43CA153784NCI NIH HHS CA019014NCI NIH HHS CA16086NCI NIH HHS D43 CA153784NCI NIH HHS P01 CA019014NCI NIH HHS P30 CA016086NIDCR NIH HHS DE018304NIDCR NIH HHS R01 DE018304
6 · The paper itself

Abstract

backgroundThe most common human papillomavirus (HPV) genotypes isolated from cervical cancer in select African countries are HPV-16, HPV-18, HPV-35, and HPV-45, but the most common genotypes in Zambia are unknown. The overall objective of this study was to assess the potential impact of current HPV vaccines in preventing cervical cancer in Zambia, by determining the combined prevalence of HPV-16 and/or HPV-18 in invasive cervical cancer (ICC) and high-grade pre-cancer [cervical intraepithelial neoplasia 2 or 3 (CIN2/3)] cases.

findingsWe compared DNA extraction techniques to determine which assay performs well in the Zambian context, where unbuffered formalin is used to fix specimens. We then tested specimens with the Abbott RealTime High-Risk HPV test to estimate the prevalence of HPV-16/18 in formalin-fixed, paraffin-embedded ICC and CIN2/3 specimens. DNA extraction using heat (without xylene) was more successful than xylene-based extraction. Over 80% of specimens tested using heat extraction and the Abbott RealTime HPV test were positive for HPV. HPV-16 and/or HPV-18 were identified in 65/93 (69.9%) ICC specimens positive for HPV and in 38/65 (58.5%) CIN2/3 specimens positive for HPV.

conclusionsTo our knowledge this is the first report to identify HPV genotypes in cervical cancers in Zambia. A combined HPV-16/18 prevalence of 69.9% in ICC specimens suggests that current vaccines will be highly protective against cervical cancer in Zambia.

Indexed as

Cervix UteriCross-Sectional StudiesDNA, ViralFemaleGenotyping TechniquesHuman papillomavirus 16Human papillomavirus 18HumansPapillomavirus VaccinesPrevalenceUterine Cervical NeoplasmsZambiaDNA, ViralPapillomavirus Vaccines

Identifiers

PMID25591541
PMCPMC4304620
OpenAlexW2032680410

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.